Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292324206> ?p ?o ?g. }
- W4292324206 abstract "Abstract Despite therapeutic advancements, oral cavity squamous cell carcinoma (OCSCC) remains a difficult disease to treat. Systemic platinum-based chemotherapy often leads to dose-limiting toxicity (DLT), affecting quality of life. PRV111 is a nanotechnology-based system for local delivery of cisplatin loaded chitosan particles, that penetrate tumor tissue and lymphatic channels while avoiding systemic circulation and toxicity. Here we evaluate PRV111 using animal models of oral cancer, followed by a clinical trial in patients with OCSCC. In vivo, PRV111 results in elevated cisplatin retention in tumors and negligible systemic levels, compared to the intravenous, intraperitoneal or intratumoral delivery. Furthermore, PRV111 produces robust anti-tumor responses in subcutaneous and orthotopic cancer models and results in complete regression of carcinogen-induced premalignant lesions. In a phase 1/2, open-label, single-arm trial (NCT03502148), primary endpoints of efficacy (≥30% tumor volume reduction) and safety (incidence of DLTs) of neoadjuvant PRV111 were reached, with 69% tumor reduction in ~7 days and over 87% response rate. Secondary endpoints (cisplatin biodistribution, loco-regional control, and technical success) were achieved. No DLTs or drug-related serious adverse events were reported. No locoregional recurrences were evident in 6 months. Integration of PRV111 with current standard of care may improve health outcomes and survival of patients with OCSCC." @default.
- W4292324206 created "2022-08-19" @default.
- W4292324206 creator A5000536355 @default.
- W4292324206 creator A5001508323 @default.
- W4292324206 creator A5003842701 @default.
- W4292324206 creator A5005921034 @default.
- W4292324206 creator A5014820649 @default.
- W4292324206 creator A5018004246 @default.
- W4292324206 creator A5018293614 @default.
- W4292324206 creator A5020728119 @default.
- W4292324206 creator A5020792131 @default.
- W4292324206 creator A5020795619 @default.
- W4292324206 creator A5021429069 @default.
- W4292324206 creator A5030538442 @default.
- W4292324206 creator A5031626209 @default.
- W4292324206 creator A5032978918 @default.
- W4292324206 creator A5038745727 @default.
- W4292324206 creator A5044046550 @default.
- W4292324206 creator A5045242046 @default.
- W4292324206 creator A5047365774 @default.
- W4292324206 creator A5053487762 @default.
- W4292324206 creator A5058226349 @default.
- W4292324206 creator A5061656341 @default.
- W4292324206 creator A5068758552 @default.
- W4292324206 creator A5069558252 @default.
- W4292324206 creator A5080716811 @default.
- W4292324206 creator A5082834975 @default.
- W4292324206 creator A5087479014 @default.
- W4292324206 creator A5087769926 @default.
- W4292324206 creator A5089913936 @default.
- W4292324206 creator A5090147446 @default.
- W4292324206 creator A5090838237 @default.
- W4292324206 creator A5091099302 @default.
- W4292324206 date "2022-08-17" @default.
- W4292324206 modified "2023-10-18" @default.
- W4292324206 title "A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer" @default.
- W4292324206 cites W1486369761 @default.
- W4292324206 cites W1574872111 @default.
- W4292324206 cites W1608726140 @default.
- W4292324206 cites W1911130923 @default.
- W4292324206 cites W1930271313 @default.
- W4292324206 cites W1967962637 @default.
- W4292324206 cites W1969528363 @default.
- W4292324206 cites W1970151745 @default.
- W4292324206 cites W1970351776 @default.
- W4292324206 cites W1976185658 @default.
- W4292324206 cites W1976794537 @default.
- W4292324206 cites W1981853649 @default.
- W4292324206 cites W1985419631 @default.
- W4292324206 cites W1993571679 @default.
- W4292324206 cites W1995154746 @default.
- W4292324206 cites W1998516723 @default.
- W4292324206 cites W2002975535 @default.
- W4292324206 cites W2003495186 @default.
- W4292324206 cites W2005645516 @default.
- W4292324206 cites W2008161586 @default.
- W4292324206 cites W2010181731 @default.
- W4292324206 cites W2010854729 @default.
- W4292324206 cites W2018313793 @default.
- W4292324206 cites W2021328544 @default.
- W4292324206 cites W2022082662 @default.
- W4292324206 cites W2024587581 @default.
- W4292324206 cites W2026070406 @default.
- W4292324206 cites W2027876233 @default.
- W4292324206 cites W2029409133 @default.
- W4292324206 cites W2029603310 @default.
- W4292324206 cites W2029891359 @default.
- W4292324206 cites W2033855791 @default.
- W4292324206 cites W2041247778 @default.
- W4292324206 cites W2047568538 @default.
- W4292324206 cites W2049969854 @default.
- W4292324206 cites W2050160438 @default.
- W4292324206 cites W2061705222 @default.
- W4292324206 cites W2061831048 @default.
- W4292324206 cites W2072435700 @default.
- W4292324206 cites W2072894301 @default.
- W4292324206 cites W2073131323 @default.
- W4292324206 cites W2077834005 @default.
- W4292324206 cites W2078270553 @default.
- W4292324206 cites W2083670951 @default.
- W4292324206 cites W2084554859 @default.
- W4292324206 cites W2109285181 @default.
- W4292324206 cites W2112167498 @default.
- W4292324206 cites W2114889530 @default.
- W4292324206 cites W2117631891 @default.
- W4292324206 cites W2120271041 @default.
- W4292324206 cites W2121762276 @default.
- W4292324206 cites W2122741198 @default.
- W4292324206 cites W2147504123 @default.
- W4292324206 cites W2152609192 @default.
- W4292324206 cites W2153046528 @default.
- W4292324206 cites W2153841693 @default.
- W4292324206 cites W2155127143 @default.
- W4292324206 cites W2172117269 @default.
- W4292324206 cites W2173072896 @default.
- W4292324206 cites W2194286561 @default.
- W4292324206 cites W2264122567 @default.
- W4292324206 cites W2282664279 @default.
- W4292324206 cites W2291608360 @default.
- W4292324206 cites W2316636592 @default.